524314 Stock Overview
Gujarat Terce Laboratories Limited manufactures, markets, and distributes medicines and healthcare products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Gujarat Terce Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹70.22 |
| 52 Week High | ₹70.91 |
| 52 Week Low | ₹16.65 |
| Beta | 0.85 |
| 1 Month Change | 53.49% |
| 3 Month Change | 111.83% |
| 1 Year Change | 231.23% |
| 3 Year Change | 883.47% |
| 5 Year Change | 740.96% |
| Change since IPO | 830.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524314 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 21.5% | -1.4% | -1.6% |
| 1Y | 231.2% | 53.7% | 45.0% |
Return vs Industry: 524314 exceeded the Indian Pharmaceuticals industry which returned 53.7% over the past year.
Return vs Market: 524314 exceeded the Indian Market which returned 45% over the past year.
Price Volatility
| 524314 volatility | |
|---|---|
| 524314 Average Weekly Movement | 9.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524314's share price has been volatile over the past 3 months.
Volatility Over Time: 524314's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 358 | Aalap Prajapati | www.gujaratterce.in |
Gujarat Terce Laboratories Limited manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company’s products include branded generic pharmaceutical covering various therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastroenterology, gynecology, pain therapy, and ayurvedic. It provides its products in various forms, including tablets, capsules, oral liquids, ointments, and injections under the Acolate, Codimol, Resplash, Terafloraz, Thyter, Tynol, Vitfol, Ferlit, Aziter, and Z-Oxi brands.
Gujarat Terce Laboratories Limited Fundamentals Summary
| 524314 fundamental statistics | |
|---|---|
| Market cap | ₹521.05m |
| Earnings (TTM) | ₹5.03m |
| Revenue (TTM) | ₹486.56m |
103.5x
P/E Ratio1.1x
P/S RatioIs 524314 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524314 income statement (TTM) | |
|---|---|
| Revenue | ₹486.56m |
| Cost of Revenue | ₹189.17m |
| Gross Profit | ₹297.39m |
| Other Expenses | ₹292.35m |
| Earnings | ₹5.03m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.68 |
| Gross Margin | 61.12% |
| Net Profit Margin | 1.03% |
| Debt/Equity Ratio | 96.9% |
How did 524314 perform over the long term?
See historical performance and comparison